Posted on 09/11/2021 8:57:53 AM PDT by uzumaki_naruto
Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease. The candidate showed 100% protection against moderate and severe disease. In people at high risk of developing complications from COVID-19 (people 65 years or older and people under age 65 with certain comorbidities or with likely regular exposure to COVID-19), the vaccine showed 91.0% efficacy in preventing symptomatic COVID-19 disease.
(Excerpt) Read more at nih.gov ...
Thanks, something to keep an eye on.
Emphasizing that I'm not medically trained, mRNA technology may be triggering pulmonary arterial hypertension which may take roughly three years to kill a patient according to a few threads.
From shots to clots: considerable medical evidence of COVID vaccine-induced blood clots (8.16.21)
More specifically, the protein spikes introduced by mRNA "vaccines" may be getting stuck in the walls of capillary blood vessels. If such is the case, then the protein spikes may be impeding the flow of blood through the capillary causing microscopic blood clots to form. The clots force the heart to work harder and harder until the heart can no longer do its job.
If I understand correctly, concerned medical experts ran the D-dimer blood clot-related test on people a few days after they were jabbed, the tests results indicating recent blood clot activity.
In other words, if microscopic blood clots are forming because of mRNA "vaccines," then clinical trial results need at least three years to be conclusive about this possible situation in my non-medical opinion.
Corrections, insights welcome.
We move on to some other designator, yes.
—
There are between 80,000-106,000 Chinese characters each unique and a more fitting designator system considering it’s origin. That many characters should last for at least the duration of the Joek’s several terms and well into term of the dictator who follows.
Bttt.
5.56mm
The foundation for developing new or improved vaccines is basic research in microbiology, immunology, and disease pathogenesis. This research is largely carried out at the NIH, DoD (understandably, DoD's efforts are oriented toward military needs), universities, and biotechnology firms; it is funded by federal grants, private foundations, and the biotechnology industry. The level of effort reflects the priority decisions of the funding organizations—principally, the NIAID and DoD.
Applied research, which leads directly to vaccine development, is also funded by the NIAID, often through contracts, and by DoD. There is also significant investment at this level by industry. The rate of progress in any given field can be strongly influenced by the level of NIAID and DoD funding, as is the case with HIV vaccine research.
The decision to move a vaccine candidate from laboratory research to industrial development is in the hands of the private sector vaccine manufacturers. It is based on an assessment of technical feasibility, estimated development costs, and market analysis (including the potential for liability problems). In most cases, public policy only indirectly influences the decision to pursue vaccine development and thus has little effect on the character of the vaccines that eventually enter the marketplace.
During the course of vaccine development but before licensure, there is a requirement for a series of studies to prove clinical safety and efficacy. Government support for this phase of the development process is becoming increasingly common and varies in extent, depending on the priorities of NIH and the willingness of the vaccine's developers to cooperate with government agencies. Government support of these studies is an important subsidization of the vaccine development process.
On the demand side, the purchase, distribution, and administration of vaccines are carried out through a mixture of federal, state, and private sector activities. The FDA subserves the regulatory role in vaccine licensing; the CDC is a major buyer of vaccines for federal and state programs, purchasing more than half of the vaccines used for childhood immunizations in the United States. The cost to consumers of vaccines purchased by the CDC is much lower than the cost of vaccines sold by the private sector market. Policies for the use of vaccines are developed by the Immunization Practices Advisory Committee, a CDC advisory committee, within the licensed-use guidelines set by the FDA.
Many decisions influence the life cycle of a new vaccine. In the public sector, such decisions are made independently by a number of agencies or committees (e.g., the FDA, CDC, Immunization Practices Advisory Committee [ACIP]) and are loosely coordinated by the PHS through its National Vaccine Program Office. (This agency is a coordinating office for the PHS but has no directive authority.) Corporate decision making responds primarily to market forces. The relationship between the public and private sectors is defined mainly by FDA guidelines and federal purchasing regulations and, as a result, is as often confrontational as cooperative.
Advances in immunology, molecular biology, biochemistry, and drug delivery systems have stimulated major new initiatives in vaccine development. The generation of vaccines that will come into use in the next decade is likely to be different from previous generations of vaccines. Some will contain more than one highly purified antigen and will rely on new delivery methods. Programmed-release biodegradable microspheres offer the possibility of single-dose regimens for parenteral vaccines. New oral vaccination methods will improve our ability to protect against enteric and respiratory agents.
Extensive investigations are also centering on vaccines that use attenuated viruses and bacteria as vectors to introduce specific antigenic components of disease-causing microbes. For example, a fowlpox virus recombinant, which has had parts of the genome of rabies virus inserted into its DNA, has been tested in animals to determine its ability to induce immunity to rabies. In two of five vertebrate species examined in one study, inoculation of the fowlpox recombinant vaccine candidate resulted in the induction of an immune response that protected against subsequent challenge with live rabies virus (Taylor et al., 1988). Other attenuated organisms being considered for use as vaccine vectors are vaccinia virus, baculovirus, poliovirus, Salmonella typhimurium, and bacille Calmette-Guerin (BCG). A major advantage of the vectored vaccine concept is that the vector genome can accommodate genetic material from more than one agent (perhaps as many as six or more); thus, it might be possible to develop a single vaccine that would immunize a person against multiple agents. This area offers much promise for the future of vaccine development.
For all of their potential, however, vaccines should not be viewed as so-called magic bullets for defeating emerging microbial threats. The potential value of vaccination and the speed with which vaccines can be developed depend on many factors. Especially important are the existing scientific knowledge of the agent (or similar organisms), its molecular biology, rate of transmission, pathogenesis, how the human immune system responds to natural infection, and the nature of the protective immunity the vaccine induces.
There is more, for being a chapter of a book it is pretty comprehensive. To me it sounds like the outline of what we are facing.
The vaccine industry is pure evil and fraudulent
Believe NOTHING THEY EVER SAY ABOUT THEIR POISONOUS CRAP
My family and I were thinking about Novavax, but not any more.
At point we have been lied too so much by the medical community, big pharmacy, our government, and others that are around pushing the vax that we will not take any of these vaccines because we cannot trust the people pushing them.
Anyone who is ignoring the adverse reactions to the vaccines and censoring and lying about the existing effective therapeutics, does not have our best interests at heart. At this point I am convinced it’s all about money, control and agendas.
No thanks.
“t we will not take any of these vaccines because we cannot trust the people pushing them.”
At least in the USA I do not think anybody is pushing Novavax. It appears they are trying to prevent it from being an option. FDA keeps blocking and slow playing Novavax.
Are the powers to be heavily invested in the other vaccines where Novavax will lower their profits?
“What about all the other strains between Mu and Omega? Do we move on, after exhausting the Greek alphabet, to Chinese characters?”
Have to wonder how natural antibodies will work against future strains?
Do our nature antibodies get better with each infection?
We’ll see. All I know is I will be closely watching who is for and who is against this shot and how it performs in the real world long term.
An aborted baby was involved. Thats all I need to know
Spike proteins are safe?
I guess, when the Novavax folks start buying Hunter-art, we’ll know somethings amiss...
“Have they ever isolated the virus? I’ve read that they haven’t. And is that a reason that these “vaccines” which aren’t really vaccines, are doing weird things to peoples bodies?”
Novavax is looking to apply for EUA in the U.S. in Q4 2021.
Europe has already ordered 200M doses.
I will not take an mRNA jab, but would consider this vaccine, which follows a more traditional approach to development, without the clotting and other thrombotic VAX-responses that have scared the sane and educated away...
I will NOT be surprised if Novavax approval is denied in the U.S., as it will not line Fauci and his cronies pockets.
Won’t take that one, either.
That’s wonderful. We can trust the liars now!
https://pubmed.ncbi.nlm.nih.gov/32563608/
Vaccination against coronaviruses in domestic animals
The current pandemic of COVID-19 has set off an urgent search for an effective vaccine. This search may well benefit from the experiences of the animal health profession in the development and use of coronavirus vaccines in domestic animal species. These animal vaccines will in no way protect humans against COVID-19 but knowledge of the difficulties encountered in vaccinating animals may help avoid or minimize similar problems arising in humans. Diverse coronaviruses can infect the domestic species from dogs and cats, to cattle and pigs to poultry. Many of these infections are controlled by routine vaccination. Thus, canine coronavirus vaccines are protective in puppies but the disease itself is mild and self-limiting. Feline coronavirus infections may be mild or may result in a lethal immune-mediated disease - feline infectious peritonitis. As a result, vaccination of domestic cats must seek to generate- protective immunity without causing immune-mediated disease. Vaccines against bovine coronavirus are widely employed in cattle where they protect against enteric and respiratory disease in young calves. Two major livestock species suffer from economically significant and severe coronavirus diseases. Thus, pigs may be infected with six different coronaviruses, one of which, porcine epidemic diarrhea, has proven difficult to control despite the development of several innovative vaccines. Porcine epidemic diarrhea virus undergoes frequent genetic changes. Likewise, infectious bronchitis coronavirus causes an economically devastating disease of chickens. It too undergoes frequent genetic shifts and as a result, can only be controlled by extensive and repeated vaccination. Other issues that have been encountered in developing these animal vaccines include a relatively short duration of protective immunity, and a lack of effectiveness of inactivated vaccines. On the other hand, they have been relatively cheap to make and lend themselves to mass vaccination procedures.
This vaccine delivers them in a bundle, not individually. My guess is this allows the immune system to attack the protein without the protein being cytotoxic form. If you really want to know you can call them; they actually do answer.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.